Four other non-lethal scenarios documented in adolescents using tramadol for musculoskeletal pain or sciatica described unresponsiveness or somnolence soon after a person or a number of doses of tramadol; all essential health care intervention. Two of such were U.S. cases. If this SPL has inactivated NDCs listed via the FDA initiated compliance